Microsatellite Instability and p53 Mutations Are Associated With Abnormal Expression of the MSH2 Gene in Adult Acute Leukemia
Abstract
Microsatellite instability (MSI) and p53 mutations have been reported to occur in a significant proportion of patients with therapy-related acute myeloid leukemia (AML). MSH2 is one of the genes involved in DNA mismatch repair to maintain fidelity of genomic replication, and defects of MSH2 are directly involved in MSI in hereditary nonpolyposis colorectal tumors and other human tumors. We have examined the expression of MSH2 protein by Western blotting in 43 adult leukemia samples, including 42 AML and 1 acute lymphoblastic leukemia (ALL) using the antibody MSH2 (Ab-1) (Calbiochem, La Jolla, CA). Abnormal expression of MSH2 protein was found in 14 of 43 (32.6%) cases; a control antibody to actin was always positive. Of the 14 patients that had abnormal expression of MSH2, 2 had therapy-related acute leukemia and 9 were elderly patients (>60 years of age). Expression of MSH2 mRNA was further examined by reverse transcriptase-polymerase chain reaction (RT-PCR). Deletion of MSH2 mRNA was found in 1 of 14 cases with deficient MSH2 protein expression. This group of patients was also screened for loss of heterozygosity (LOH) at the MSH2 locus using a panel 4 microsatellite markers (D2S367, D2S288, D2S391, and D2S2294). LOH was found in 5 of 11 cases examined. There was no evidence of LOH in 14 patients with normal MSH2 expression who were examined using the same markers. Functional evidence for defective DNA mismatch repair in leukemic cells lacking MSH2 as manifest by MSI was found in 7 of 11 cases studied. Mutations of the p53 gene in these 43 samples were also investigated by direct sequencing of full-length p53 cDNA. Mutations of p53 were found in 6 of 43 cases, including 5 of the 14 (35.7%) cases that did not express MSH2 protein. In contrast, mutation of p53 was only found in 1 of 29 (3.4%) cases with normal MSH2 protein expression (χ2 = 5.720, P < .02). These results suggest that abnormalities of DNA mismatch repair due to defective MSH2 expression could play a key role in leukemogenesis, in particular in AML arising in elderly patients or secondary to previous chemotherapy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Impaired DNA mismatch repair plays a role in leukemogenesis.
“several lines of evidence support a role of impaired DNA mismatch repair (MMR) in leukemogenesis23–25.”
From Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia (2015) · cites this paper as [24]
Cites
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138 · see citing works
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864 · see citing works
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R. A., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J. E., Kane, M., & Kolodner, R. D. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,857 · see citing works
Ionov, Y., Peinado, M. A., Malkhosyan, S. R., Shibata, D. K., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,707 · see citing works
Grimwade, D. J., Walker, H., Oliver, F., Wheatley, K., Harrison, C. J., Harrison, G., Rees, J., Hann, I. M., Stevens, R., Burnett, A. K., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,649 · see citing works
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271 · see citing works
MISMATCH REPAIR IN REPLICATION FIDELITY, GENETIC RECOMBINATION, AND CANCER BIOLOGY
Modrich, P. L., & Lahue, R. S. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.000533 · Cited by 1,510 · see citing works
Leith, C. P., Kopecky, K. J., Godwin, J. E., McConnell, T. S., Slovak, M. L., Chen, I.-M., Head, D. R., Appelbaum, F. R., & Willman, C. L. (1997) · Blood · doi:10.1182/blood.v89.9.3323 · Cited by 859 · see citing works
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability
Liu, B., Nicolaides, N. C., Markowitz, S. D., Willson, J. K. V., Parsons, R. E., Jen, J., Papadopolous, N., Peltomäki, P., de la Chapelle, A., Hamilton, S. R., et al. (1995) · Nature Genetics · doi:10.1038/ng0195-48 · Cited by 801 · see citing works
p53: oncogene or anti-oncogene?Preprint
Lane, D. P., & Benchimol, S. (1990) · Genes & Development · doi:10.1101/gad.4.1.1 · Cited by 796 · see citing works
de Wind, N., Dekker, M., Berns, A. J. M., Radman, M., & Riele, H. T. (1995) · Cell · doi:10.1016/0092-8674(95)90319-4 · Cited by 780 · see citing works
A Southwest Oncology Group study
Jenkins, T. R., Tangen, C. M., Macdonald, J. S., Weiss, G. R., Chapman, R. M., & Hantel, A. (1993) · Cited by 773 · see citing works
Wattel, E., Preudhomme, C., Hecquet, B., Vanrumbeke, M., Quesnel, B., Dervite, I., Morel, P., & Fenaux, P. (1994) · Blood · doi:10.1182/blood.v84.9.3148.3148 · Cited by 592 · see citing works
Thibodeau, S. N., French, A. J., Roche, P. C., Cunningham, J. M., Tester, D. J., Lindor, N. M., Möslein, G., Baker, S. M., Liskay, R. M., Burgart, L. J., et al. (1996) · PubMed · Cited by 466 · see citing works
Instability of short tandem repeats (microsatellites) in human cancers
Wooster, R., Cleton-Jansen, A. M., Collins, N., Mangion, J., Cornelis, R. S., Cooper, C. S., Gusterson, B. A., Ponder, B. A. J., von Deimling, A., Wiestler, O. D., et al. (1994) · Nature Genetics · doi:10.1038/ng0294-152 · Cited by 404 · see citing works
MSH2 deficient mice are viable and susceptible to lymphoid tumours
Reitmair, A. H., Schmits, R., Ewel, A., Bapat, B. V., Redston, M. S., Mitri, A., Waterhouse, P. D., Mittrücker, H., Wakeham, A. C., Liu, B., et al. (1995) · Nature Genetics · doi:10.1038/ng0995-64 · Cited by 376 · see citing works
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds.
Liu, B., Parsons, R. E., Hamilton, S. R., Petersen, G. M., Lynch, H. T., Watson, P., Markowitz, S. D., Willson, J. K. V., Green, J., & de la Chapelle, A. (1994) · PubMed · Cited by 360 · see citing works
Vogelstein, B. (1990) · Nature · doi:10.1038/348681a0 · Cited by 332 · see citing works
Umar, A., Boyer, J. C., Thomas, D. C., Nguyen, D. H. V., Risinger, J. I., Boyd, J. A., Ionov, Y., Perucho, M., & Kunkel, T. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36630-9 · Cited by 331 · see citing works
Boyer, J. C., Umar, A., Risinger, J. I., Lipford, J. R., Kane, M., Yin, S., Barrett, J. C., Kolodner, R. D., & Kunkel, T. A. (1995) · PubMed · Cited by 307 · see citing works
Structure of the Human MSH2 Locus and Analysis of Two Muir-Torre Kindreds for msh2 Mutations
Kolodner, R. D., Hall, N. R., Lipford, J. R., Kane, M., Rao, M. R. S., Morrison, P., Wirth, L. J., Finan, P. J., Burn, J., Chapman, P. D., et al. (1994) · Genomics · doi:10.1006/geno.1994.1661 · Cited by 276 · see citing works
Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer.
Bubb, V., Curtis, L. J., Cunningham, C., Dunlop, M. G., Carothers, A. D., Rg, M., White, S., Bird, C. C., & Wyllie, A. H. (1996) · PubMed · Cited by 246 · see citing works
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype
Ben‐Yehuda, D., Krichevsky, S., Caspi, O., Rund, D. G., Polliack, A., Abeliovich, D., Zelig, O., Bogomolski-Yahalom, V., Paltiel, O., Or, R., et al. (1996) · Blood · doi:10.1182/blood.v88.11.4296.bloodjournal88114296 · Cited by 192 · see citing works
DNA mismatch repair and cancer
Chung, D. C., & Rustgi, A. K. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90660-6 · Cited by 179 · see citing works
Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood
Wada, M., Bartram, C., Nakamura, H., Hachiya, M., Chen, D., Borenstein, J. E., Cw, M., Ludwig, L., Hansen-Hagge, T., & Ludwig, W. (1993) · Blood · doi:10.1182/blood.v82.10.3163.3163 · Cited by 179 · see citing works
Brimmell, M., Mendiola, R., Mangion, J., & Packham, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201704 · Cited by 168 · see citing works
Binding of Mismatched Microsatellite DNA Sequences by the Human MSH2 Protein
Fishel, R. A., Ewel, A., Lee, S., Lescoe, M. K., & Griffith, J. D. (1994) · Science · doi:10.1126/science.7973733 · Cited by 164 · see citing works
Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas
Børresen‐Dale, A., Lothe, R. A., Meling, G., Lystad, S., Morrison, P., Lipford, J. R., Kane, M., Rognum, T. O., & Kolodner, R. D. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.11.2065 · Cited by 163 · see citing works
Genetic instability in human ovarian cancer cell lines.
Orth, K., Hung, J. Y., Gazdar, A. F., Bowcock, A. M., Mathis, J. M., & Sambrook, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9495 · Cited by 128 · see citing works
Mutation of the p53 gene in human acute myelogenous leukemia
Slingerland, J., Minden, M., & Benchimol, S. (1991) · Blood · doi:10.1182/blood.v77.7.1500.bloodjournal7771500 · Cited by 128 · see citing works
Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia
Diccianni, M. B., Yu, A. L.-T., Hsiao, M., Mukherjee, S., Shao, L.-E., & Yu, A. L.-T. (1994) · Blood · doi:10.1182/blood.v84.9.3105.3105 · Cited by 123 · see citing works
Mutations of the P53 gene in acute myeloid leukaemia
Fenaux, P., Preudhomme, C., Quiquandon, I., Jonveaux, P., Laı̈, J. L., Vanrumbeke, M., Loucheux‐Lefebvre, M. H., Bauters, F., Berger, R., & Kerckaert, J. P. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb08897.x · Cited by 117 · see citing works
Lazar, V., Grandjouan, S., Bognel, C., Couturier, D., Rougier, P. R., Bellet, D. H., & Paillerets, B. B. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.12.2257 · Cited by 93 · see citing works
Purified human MSH2 protein binds to DNA containing mismatched nucleotides.
Fishel, R. A., Ewel, A., & Lescoe, M. K. (1994) · PubMed · Cited by 89 · see citing works
Hsiao, M., Yu, A. L.-T., Yeargin, J., Ku, D., & Haas, M. (1994) · Blood · doi:10.1182/blood.v83.10.2922.2922 · Cited by 82 · see citing works
Lowsky, R., DeCoteau, J. F., Reitmair, A. H., Ichinohasama, R., Dong, W.-F., Xu, Y., Mak, T. W., Kadin, M. E., & Minden, M. D. (1997) · Blood · doi:10.1182/blood.v89.7.2276 · Cited by 78 · see citing works
Expression of human MutS homolog 2 (hMSH2) protein in resting and proliferating cells.
Marra, G., Chang, C., Laghi, L., Chauhan, D. P., Young, D. J., & Boland, C. R. (1996) · PubMed · Cited by 71 · see citing works
Percesepe, A., Kristo, P., Aaltonen, L. A., de Leòn, M. P., de la Chapelle, A., & Peltomäki, P. (1998) · Oncogene · doi:10.1038/sj.onc.1201944 · Cited by 71 · see citing works
Cell cycle regulation of the human DNA mismatch repair genes hMSH2, hMLH1, and hPMS2.
Meyers, M., Theodosiou, M., Acharya, S., Odegaard, E., Wilson, T., Lewis, J. E., Davis, T. W., Patten, C. W.-V., Fishel, R. A., & Boothman, D. A. (1997) · PubMed · Cited by 61 · see citing works
P53 gene mutations in acute myelogenous leukaemia
Hu, G., Zhang, W., & Deisseroth, A. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb02979.x · Cited by 56 · see citing works
Microsatellite instability during the progression of acute myelocytic leukaemia
Tasaka, T., Lee, S., Spira, S., Takeuchi, S., Nagai, M., Takahara, J., & Koeffler, H. P. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.1672985.x · Cited by 43 · see citing works
Rarity of microsatellite alterations in acute myeloid leukaemia
Sill, H., Goldman, J. M., & Cross, N. C. P. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.347 · Cited by 36 · see citing works
Zhu, Y., Foroni, L., McQuaker, I. G., Papaioannou, M., Haynes, A. P., & Russell, H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690183 · Cited by 36 · see citing works
Self-citation
Flagged first, then by citations
4 of the 47 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Grimwade, D. J. (2001) · Blood · doi:10.1182/blood.v98.5.1312 · Cited by 917 · see citing works
p53: traffic cop at the crossroads of DNA repair and recombination
Sengupta, S., & Harris, C. C. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1546 · Cited by 544 · see citing works
Mechanisms of therapy-related carcinogenesis
Allan, J. M., & Travis, L. B. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1749 · Cited by 277 · see citing works
Tumor suppressor genes in normal and malignant hematopoiesis
Krug, U. O., Ganser, A., & Koeffler, H. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205322 · Cited by 229 · see citing works
Therapy-Related Myelodysplasia and Acute Myeloid Leukemia
Bhatia, R. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.09.013 · Cited by 220 · see citing works
Seedhouse, C., Bainton, R. D., Lewis, M. D., Harding, A., Russell, N. H., & Das-Gupta, E. P. (2002) · Blood · doi:10.1182/blood-2002-04-1152 · Cited by 182 · see citing works
Self-citationDNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias.
Leone, G. G. M., Teofili, L., Voso, M. T., & Lübbert, M. (2002) · PubMed · Cited by 167 · see citing works
Seedhouse, C., Faulkner, R. D., Ashraf, N., Das-Gupta, E. P., & Russell, N. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0372 · Cited by 164 · see citing works
Self-citationSmith, M. T., Wang, Y., Kane, E. V., Rollinson, S. J., Wiemels, J. L., Roman, E., Roddam, P. L., Cartwright, R. A., & Morgan, G. J. (2001) · Blood · doi:10.1182/blood.v97.5.1422 · Cited by 145 · see citing works
TP53 in hematological cancer: Low incidence of mutations with significant clinical relevance
PELLER, S., & Rotter, V. (2003) · Human Mutation · doi:10.1002/humu.10190 · Cited by 141 · see citing works
Therapy Related Leukemias: Susceptibility, Prevention and Treatment
Leone, G. G. M., Voso, M. T., Sica, S., Roberta Morosetti, A., & Pagano, L. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109057981 · Cited by 133 · see citing works
Diouf, B., Cheng, Q., Krynetskaia, N. F., Yang, W., Cheok, M., Pei, D., Fan, Y., Cheng, C., Krynetskiy, E. Y., Geng, H., et al. (2011) · Nature Medicine · doi:10.1038/nm.2430 · Cited by 129 · see citing works
Will, B., Vogler, T. O., Narayanagari, S., Bartholdy, B., Todorova, T. I., da Silva Ferreira, M., Chen, J., Yu, Y., Mayer, J., Barreyro, L., et al. (2015) · Nature Medicine · doi:10.1038/nm.3936 · Cited by 127 · see citing works
RAD51, genomic stability, and tumorigenesis
Richardson, C. A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.08.009 · Cited by 118 · see citing works
Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS
Leone, G. G. M., Voso, M. T., Teofili, L., & Lübbert, M. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00207-9 · Cited by 112 · see citing works
The Difficult Problem of Acute Myeloid Leukemia in the Older Adult
Stone, R. M. (2002) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.363 · Cited by 97 · see citing works
Repopulating defect of mismatch repair–deficient hematopoietic stem cells
Reese, J., Liu, L., & Gerson, S. L. (2003) · Blood · doi:10.1182/blood-2002-10-3035 · Cited by 89 · see citing works
Esposito, M., & So, C. (2014) · Chromosoma · doi:10.1007/s00412-014-0482-9 · Cited by 85 · see citing works
DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy
de Almeida, L. C., Calil, F. A., Machado‐Neto, J. A., & Costa-Lotufo, L. V. (2020) · Cancer Genetics · doi:10.1016/j.cancergen.2020.12.002 · Cited by 86 · see citing works
Rund, D. G., Krichevsky, S., Cohen, S. B., Goldschmidt, N., Kedmi, M., Malik, E., Gural, A., Shafran‐Tikva, S., Ben‐Neriah, S., & Ben‐Yehuda, D. (2005) · Leukemia · doi:10.1038/sj.leu.2403947 · Cited by 80 · see citing works
Advances in the understanding of susceptibility to treatment‐related acute myeloid leukaemia
Seedhouse, C., & Russell, N. H. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06613.x · Cited by 79 · see citing works
Self-citationWorrillow, L. J., Travis, L. B., Smith, A. G., Rollinson, S. J., Smith, A. J. P., Wild, C. P., Holowaty, E. J., Kohler, B., Wiklund, T. A., Pukkala, ., et al. (2003) · PubMed · doi:10.25405/ncl.34299504 · Cited by 76 · see citing works
Morton, L. M., Saber, W., Baker, K. S., Barrett, A. J., Bhatia, S., Engels, E. A., Gadalla, S. M., Kleiner, D. E., Pavletic, S. Z., & Burns, L. J. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.09.005 · Cited by 65 · see citing works
Scarisbrick, J. J., Mitchell, T. J., Calonje, E. J., Orchard, G. E., Russell‐Jones, R., & Whittaker, S. J. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12496.x · Cited by 57 · see citing works
Bucci, B., D’Agnano, I., Amendola, D., Citti, A., Raza, G. H., Miceli, R., Paula, U. D., Marchese, R., Albini, S., Felsani, A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1582 · Cited by 57 · see citing works
Xinarianos, G., Liloglou, T., Prime, W., Maloney, P. J., Callaghan, J., Fielding, P., Gosney, J. R., & Field, J. K. (2000) · PubMed · Cited by 56 · see citing works
Reduced expression of human mismatch repair genes in adult T-cell leukemia
Morimoto, H., Tsukada, J., Kominato, Y., & Tanaka, Y. (2005) · American Journal of Hematology · doi:10.1002/ajh.20259 · Cited by 54 · see citing works
Seedhouse, C., Das-Gupta, E. P., & Russell, N. H. (2003) · Leukemia · doi:10.1038/sj.leu.2402747 · Cited by 54 · see citing works
Self-citationSheikhha, M. H., Tobal, K., & Yin, A. L. J. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03458.x · Cited by 53 · see citing works
Casorelli, I. (2003) · DNA repair · doi:10.1016/s1568-7864(03)00020-x · Cited by 52 · see citing works
Matheson, E. C. (2003) · Carcinogenesis · doi:10.1093/carcin/24.1.31 · Cited by 53 · see citing works
Liso, V., Albano, F., Pastore, D., Carluccio, P., Mele, G., Lamacchia, M., Mestice, A., & Specchia, G. (2000) · PubMed · Cited by 51 · see citing works
Subsequent Malignant Neoplasms after Hematopoietic Cell Transplantation
Socié, G., Baker, K. S., & Bhatia, R. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.10.005 · Cited by 50 · see citing works
The challenge of acute myeloid leukemia in older patients
Sekeres, M. A., & Stone, R. M. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00005 · Cited by 50 · see citing works
Yan, W., Xu, L., Sun, Z., Lin, Y., Zhang, W., Chen, J., Hu, S., & Shen, B. (2015) · Oncotarget · doi:10.18632/oncotarget.4459 · Cited by 48 · see citing works
Microsatellite instability occurs in defined subsets of patients with acute myeloblastic leukaemia
Das-Gupta, E. P., Seedhouse, C., & Russell, N. H. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02920.x · Cited by 48 · see citing works
Self-citationMismatch repair deficiency in hematological malignancies with microsatellite instability
Gu, L., Cline-Brown, B., Zhang, F., Qiu, L., & Li, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205695 · Cited by 46 · see citing works
Is there an upper age limit for bone marrow transplantation?
Popplewell, L., & Forman, S. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703382 · Cited by 42 · see citing works
Bhatia, R. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0659 · Cited by 41 · see citing works
Linet, M. S., Devesa, S. S., & Morgan, G. J. (2006) · doi:10.1093/acprof:oso/9780195149616.003.0044 · Cited by 39 · see citing works
Kenyon, J. D., Fu, P., Lingas, K. T., Thomas, E. A., Saurastri, A., Guasch, G. L. S., Wald, D. N., & Gerson, S. L. (2012) · Blood · doi:10.1182/blood-2011-12-401950 · Cited by 37 · see citing works
Mismatch repair defects as a cause of resistance to cytotoxic drugs
Irving, J. A. E., & Hall, A. G. (2001) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.1.1.149 · Cited by 37 · see citing works
Rahimian, E., Amini, A., Alikarami, F., Pezeshki, S. M. S., Saki, N., & Safa, M. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102951 · Cited by 35 · see citing works
Rigter, L. S., Snæbjörnsson, P., Rosenberg, E. H., Atmodimedjo, P. N., Aleman, B. M. P., ten Hoeve, J., Geurts-Giele, W. R. R., PALGA group, van Ravesteyn, T. W., Hoeksel, J., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-312608 · Cited by 34 · see citing works
Degadration of mismatch repair hMutSα heterodimer by the ubiquitin‐proteasome pathway
Hernandez-Pigeon, H., Laurent, G., Humbert, O., Salles, B., & Lautier, D. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00181-4 · Cited by 33 · see citing works
Allogeneic hematopoietic stem cell transplantation in the elderly
Shapira, M. Y., Tsirigotis, P. D., Resnick, I. B., Or, R., Abdul-Hai, A., & Slavin, S. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.01.004 · Cited by 32 · see citing works
Pallis, M., Grundy, M. A., Turzanski, J., Kofler, R., & Russell, N. H. (2001) · Blood · doi:10.1182/blood.v98.2.405 · Cited by 30 · see citing works
Self-citationTentori, L., Portarena, I., Bonmassar, E., & Graziani, G. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400832 · Cited by 30 · see citing works
Mao, G., Yuan, F., Absher, K., Jennings, C. D., Howard, D. S., Jordan, C. T., & Gu, L. (2008) · Cell Research · doi:10.1038/cr.2008.14 · Cited by 43 · see citing works
Worrillow, L. J., & Allan, J. M. (2005) · Oncogene · doi:10.1038/sj.onc.1209208 · Cited by 28 · see citing works
Humbert, O., Hermine, T., Hernandez, H., Bouget, T., Sèlves, J., Laurent, G., Salles, B., & Lautier, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103451200 · Cited by 27 · see citing works
Onda, M., Nakamura, I., Suzuki, S., Takenoshita, S., Brogren, C., Stampanoni, S., Li, D., & Rampino, N. J. (2001) · PubMed · Cited by 27 · see citing works
Xinarianos, G., Liloglou, T., Prime, W., Sourvinos, G., Karachristos, A., Gosney, J. R., Spandidos, D. A., & Field, J. K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10598 · Cited by 25 · see citing works
Fonseca, F. L., Ana, A. V. S., Bendit, I., Arias, V., Costa, L. J., Pinhal, A. A., & del Giglio, A. (2004) · Breast Cancer Research · doi:10.1186/bcr950 · Cited by 24 · see citing works
Scott, S. A., Kimura, T., Ichinohasama, R., Bergen, S., Magliocco, A. M., Reimer, C. L., Kerviche, A., Sheridan, D. P., & DeCoteau, J. F. (2002) · Leukemia Research · doi:10.1016/s0145-2126(02)00078-4 · Cited by 24 · see citing works
Lowsky, R., Magliocco, A. M., Ichinohasama, R., Reitmair, A. H., Scott, S. A., Henry, M., Kadin, M. E., & DeCoteau, J. F. (2000) · Blood · doi:10.1182/blood.v95.5.1767.005k07_1767_1772 · Cited by 24 · see citing works
Kiss, T. L., Sabry, W., Lazarus, H. M., & Lipton, J. H. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705747 · Cited by 22 · see citing works
Targeting critical regions in genomic DNA with AT-specific anticancer drugs
WOYNAROWSKI, J. M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00093-5 · Cited by 21 · see citing works
Fordham, S. E., Matheson, E. C., Scott, K. E., Irving, J. A. E., & Allan, J. M. (2011) · Leukemia · doi:10.1038/leu.2011.38 · Cited by 20 · see citing works
Sanz-Vaqué, L., Colomer, D., Bosch, F., López‐Guillermo, A., Dreyling, M. H., Bosch, F., Montserrat, E., & Campo, E. (2001) · PubMed · Cited by 19 · see citing works
Faulkner, R. D., Seedhouse, C., Das-Gupta, E. P., & Russell, N. H. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04750.x · Cited by 17 · see citing works
Self-citationTentori, L., Vernole, P., Lacal, P. M., Madaio, R., Portarena, I., Levati, L., Balduzzi, A., Turriziani, M., Dande, P., Gold, B. I., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401842 · Cited by 17 · see citing works
William, B. M., & Lima, M. J. G. D. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0076-x · Cited by 16 · see citing works
Steffen, L. S., Bacher, J., Peng, Y., Le, P. N., Ding, L.-H., Genik, P. C., Ray, F. A., Bedford, J. S., Fallgren, C. M., Bailey, S. M., et al. (2012) · Mutagenesis · doi:10.1093/mutage/ges055 · Cited by 15 · see citing works
Second Malignancy Risk After Treatment of Hodgkin Lymphoma
Hodgson, D. C., & van Leeuwen, F. E. (2014) · Hematologic malignancies · doi:10.1007/978-3-319-12505-3_24 · Cited by 14 · see citing works
Allelotype analysis of the myelodysplastic syndrome
Xie, D., Hofmann, W.-K., Mori, N., Cw, M., Hoelzer, D. T., & Koeffler, H. (2000) · Leukemia · doi:10.1038/sj.leu.2401717 · Cited by 14 · see citing works
Bret, C., Viziteu, E., Kassambara, A., & Moreaux, J. (2016) · Expert Review of Hematology · doi:10.1586/17474086.2016.1141673 · Cited by 13 · see citing works
The Role of Genomic Instability in the Development of Human Cancer
Coleman, W. B., & Tsongalis, G. J. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-125-1_6 · Cited by 13 · see citing works
Msh2 Deficiency Attenuates But Does Not Abolish Thiopurine Hematopoietic Toxicity in Msh2-- Mice
Krynetskaia, N. F., Brenner, T. L., Krynetski, E. Y., Du, W., Panetta, J. C., Pui, C., & Evans, W. E. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.456 · Cited by 12 · see citing works
Rennicke, A., Voigt, W., Mueller, T., Fruehauf, A., Schmoll, H., Beyer, C., & Dempke, W. C. M. (2005) · PubMed · Cited by 12 · see citing works
DNA repair mechanisms and acute myeloblastic leukemia
Das-Gupta, E. P., Seedhouse, C., & Russell, N. H. (2000) · Hematological Oncology · doi:10.1002/1099-1069(200009)18:3 · Cited by 11 · see citing works
Self-citationOlder adults with acute myeloid leukemia
Sekeres, M. A., & Stone, R. M. (2002) · Current Oncology Reports · doi:10.1007/s11912-002-0034-y · Cited by 11 · see citing works
Rapid and Sensitive Detection of Mycobacterium DNA Using Cepheid SmartCycler® and Tube Lysis System
Jones, M., Alland, D., Marras, S. A. E., El-Hajj, H. H., Taylor, M. T., & McMillan, W. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.10.1917 · Cited by 11 · see citing works
Microsatellite analysis in acute myeloid leukaemia evolving from myelodysplastic syndrome
Olipitz, W., Tilz, G. P., Beham‐Schmid, C., Eibinger, C., Kerzina, P., & Sill, H. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02497.x · Cited by 10 · see citing works
Korabiowska, M., Viehöver, M., Schlott, T., Berger, H., Droese, M., & Brinck, U. (2001) · Archives of Dermatological Research · doi:10.1007/s004030100220 · Cited by 9 · see citing works
Sasaki, O., Meguro, K., Tohmiya, Y., Funato, T., Shibahara, S., & Sasaki, T. (2002) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.196.193 · Cited by 8 · see citing works
Das-Gupta, E. P., & Russell, N. H. (2000) · Blood · doi:10.1182/blood.v96.5.2002 · Cited by 8 · see citing works
Self-citationThe Absence of Msh2 Alters Abelson Virus Pre-B-Cell Transformation by Influencing p53 Mutation
Jenab-Wolcott, J., Rodriguez-Correa, D. T., Reitmair, A. H., Mak, T. W., & Rosenberg, N. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8373-8381.2000 · Cited by 8 · see citing works
Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells
Qing, Y., & Gerson, S. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182175 · Cited by 7 · see citing works
Bhatia, S. (2015) · Springer eBooks · doi:10.1007/978-1-4899-7584-3_14 · Cited by 7 · see citing works
Retinal Abnormalities in Newly Diagnosed Adult Acute Myeloid Leukemia
Specchia, G., Albano, F., Guerriero, S., Buquicchio, C., Pomes, L., Pastore, D., Carluccio, P., Noci, N. D., & Liso, V. (2001) · Acta Haematologica · doi:10.1159/000046566 · Cited by 6 · see citing works
Abnormalities in Chromosomes 5 and 7 in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Kendrick, T. S., Buic, D., Fuller, K. A., & Erber, W. N. (2025) · Annals of Laboratory Medicine · doi:10.3343/alm.2024.0477 · Cited by 5 · see citing works
Matheson, E., & Hall, A. G. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg080 · Cited by 5 · see citing works
Evaluation of Temozolomide in Patients with Myelodysplastic Syndrome
Seiter, K. P., Liu, D., Siddiqui, A. D., Lerner, R., Nelson, J., & Ahmed, T. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190310001625683 · Cited by 5 · see citing works
Subsequent Malignant Neoplasms After Hematopoietic Cell Transplantation
Bhatia, R., & Bhatia, R. (2015) · Wiley eBooks · doi:10.1002/9781118416426.ch104 · Cited by 5 · see citing works
Patel, R., Qing, Y., Kennedy, L. H., Yan, Y., Pink, J. J., Aguila, B., Desai, A. B., Gerson, S. L., & Welford, S. M. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0295 · Cited by 4 · see citing works
Chapchap, E. C., Kerbauy, L. N., Esteves, I., Belucci, T. R., Rodrigues, M., Kerbauy, F. R., Santos, F. P. D. S., Ribeiro, A. A. F., & Hamerschlak, N. (2019) · European Journal of Cancer Care · doi:10.1111/ecc.13122 · Cited by 4 · see citing works
Maeck, L., Kohaus, P., Haase, D. T., Hiddemann, W., & Alves, F. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02369.x · Cited by 3 · see citing works
ASPECTOS CLÍNICOS Y EPIDEMIOLÓGICOS DE LA LEUCEMIA MIELOIDE AGUDA EN EL ANCIANO
Roldán, M. T. M., Buchillón, R. J. L., Ramírez, P. H., Llánes, O. M. A., & Monzón, E. R. (2002) · Revista cubana de hematología, inmunología y hemoterapia · Cited by 2 · see citing works
Multidrug Resistance Mechanism of Acute Lymphoblastic Leukemia
Su, Z., Zhu, H., Liu, Y., Yuan, H., Yin, J., & Xu, H. (2011) · InTech eBooks · doi:10.5772/26488 · Cited by 2 · see citing works
Magalhães, M., Oliveira, P. D., Bittencourt, A. L., & Farré, L. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003403 · Cited by 2 · see citing works
Staib, P., Lippl, S., & Spiekermann, K. (2015) · best practice onkologie · doi:10.1007/s11654-015-0247-9 · Cited by 2 · see citing works
Therapy-Related Acute Myelogenous Leukemia
Iwanski, G. B., Thoennissen, N. H., Park, D. J., & Koeffler, H. P. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3764-2_24 · Cited by 2 · see citing works
Belgrader, P., Raisi, F., Joshi, R., Nguyen, P., McMillan, W., Ching, J., Chang, R., & Northrup, M. A. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.10.1929 · Cited by 2 · see citing works
Turzanski, J., Zhu, Y., Pallis, M., & Russell, N. H. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00286-5 · Cited by 2 · see citing works
Self-citationLeukemia Relapse Reconsidered from the Molecular Aspect
Naoe, T., Nakano, Y., & Kiyoi, H. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009058504 · Cited by 2 · see citing works
Friedman, D. L. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00062-x · Cited by 2 · see citing works
Second Malignancy Risk After Treatment of Hodgkin Lymphoma
Hodgson, D. C., & van Leeuwen, F. E. (2010) · Springer eBooks · doi:10.1007/978-3-642-12780-9_22 · Cited by 2 · see citing works
Maeck, L., Kohaus, P., Haase, D. T., Hiddemann, W., & Alves, F. (2000) · British Journal of Haematology · doi:10.1111/j.1365-2141.2000.02369.x · Cited by 1 · see citing works
Mismatch repair gene promoter methylation and expression in hydatidiform moles
Chen, H., Ye, D.-F., Xie, X., Lü, W., Zhu, C., & Chen, X. (2004) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-004-0665-3 · Cited by 1 · see citing works
- Authors
- Zhu, Y.-M., Das-Gupta, E. P., & Russell, N. H.
- Affiliations
- University of Nottingham (GB)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1999-07-15
- Volume
- 94
- Issue
- 2
- Pages
- 733-740
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2206735890
- Cited by
- 118
- References
- 47
- Citations by year
- 2025: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 8 · 2014: 4 · 2013: 3 · 2012: 4
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- microsatellite instability, TP53 mutation, mismatch repair deficiency, therapy-related acute myeloid leukemia, acute lymphoblastic leukemia, loss of heterozygosity, adult leukemia, germline TP53 mutation
- MeSH terms
- Acute Disease, Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, DNA Mutational Analysis, DNA Repair, DNA-Binding Proteins, DNA, Neoplasm, Female, Humans, Karyotyping, Leukemia, Myeloid, Male, Middle Aged, Proto-Oncogene Proteins, RNA, Messenger, RNA, Neoplasm, Leukemia-Lymphoma, Adult T-Cell, Gene Expression Regulation, Leukemic, Genes, p53, DNA, Complementary, Microsatellite Repeats, Reverse Transcriptase Polymerase Chain Reaction, MutS Homolog 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review